Sureda, AnnaLugtenburg, Pieternella J.Kersten, Marie JoseSubklewe, MarionSpanjaart, AnneShah, Nirali N.Kerbauy, Lucila N.Roddie, ClariePennings, Elise R.A.Mahuad, CarolinaPoon, MichelleHendricks, Candice LaverneKamdar, ManaliJacobson, Caron2024-08-222024-08-222024-11Sureda, A., Lugtenburg, P.J., Kersten, M.J., et al. 2024, 'Cellular therapy in lymphoma. Hematological Oncology, vol. 42, no. 6, art. e3200, pp. 1‐9. https://doi.org/10.1002/hon.3200.0278-0232 (print)1099-1069 (online)10.1002/hon.3200http://hdl.handle.net/2263/97796DATA AVAILABILITY STATEMENT : Data sharing not applicable to this article as no datasets were generated or analyzed during the current study.en© 2023 John Wiley & Sons Ltd. This is the pre-peer reviewed version of the following article : Cellular therapy in lymphoma, Hematological Oncology, vol. 42, no. 6, art. e3200, pp. 1‐9. https://doi.org/10.1002/hon.3200. The definite version is available at : http://wileyonlinelibrary.com/journal/hon.Chimeric antigen receptor (CAR)T‐cell therapyLymphomaSDG-03: Good health and well-beingPostprint Article